Welcome to our dedicated page for LENSAR SEC filings (Ticker: LNSR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
LENSAR, Inc. filings document operating results and material events for a commercial-stage medical device company focused on robotic laser systems for cataract procedures. Form 8-K reports furnish quarterly and annual earnings releases, including disclosures on ALLY system activity, installed-base trends, and recurring revenue components such as procedure, lease, and service revenue.
The company’s filings also record capital and governance matters, including common stock listed on Nasdaq under LNSR, officer transition disclosures, and material agreements such as the Priority Credit Line Agreement. Amendments to material-event reports provide additional detail on credit-line terms, collateral arrangements, interest-rate mechanics, and default provisions.
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of common stock of LENSAR, INC.. BlackRock reports beneficial ownership of 184,053 shares of LENSAR common stock, representing 1.5% of the outstanding class as of the reporting date.
BlackRock has sole voting powersole dispositive power
LENSAR, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on August 4, 2026 at 11:00 a.m. Eastern Time. Investors will elect three Class III directors to terms running to the 2029 annual meeting, ratify PricewaterhouseCoopers LLP as auditor for 2026, and cast advisory votes on 2025 executive pay and how often future say‑on‑pay votes should occur, with the Board recommending every one year. Holders of 12,281,581 shares of common stock and 20,000 shares of Series A Convertible Preferred Stock as of June 10, 2026 may vote online, by phone, by mail, or during the live webcast.
LENSAR, Inc. director and 10% owner Todd B. Hammer received a grant of 17,421 restricted stock units as part of his annual non-employee director compensation. Each RSU converts into one share of common stock and vests in full on June 3, 2027, contingent on his continued service or earlier specified events. Following this grant, Hammer directly holds 56,083 common shares. Separately, 1,100,592 common shares are reported as held by North Run Capital, LP and may be deemed indirectly owned by North Run Advisors, LLC and Hammer, who disclaims beneficial ownership except to the extent of his pecuniary interest.
ELLIS THOMAS B reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director and greater-than-10% holder Thomas B. Ellis reported an equity award and updated holdings. He received 17,421 restricted stock units, each representing one share of common stock, granted at no cash cost as part of his annual non-employee director compensation.
The RSUs vest in full on June 3, 2027, if he continues serving the company, or earlier upon termination of service, a change in control, death, or disability. After this grant, he directly holds 56,083 common shares. Separately, 1,100,592 common shares are reported as indirectly held through North Run Capital, LP and North Run Advisors, LLC, with Ellis disclaiming beneficial ownership beyond his pecuniary interest.
Wong Kendra reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Principal Accounting Officer Kendra Wong received a grant of 13,066 restricted stock units (RSUs) of common stock. Each RSU represents the right to receive one share of LENSAR common stock if vesting conditions are met.
The RSUs vest in four substantially equal annual installments on each anniversary of the grant date, as long as Wong continues to provide service to the company through each vesting date. After this award, she directly holds 56,481 shares of LENSAR common stock.
Connaughton Alan B. reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Chief Operating Officer Alan B. Connaughton received a grant of 34,843 shares of common stock on June 3, 2026 in the form of restricted stock units (RSUs) at no cash cost. Each RSU represents one share of common stock and vests in four substantially equal annual installments on each anniversary of the grant date, subject to his continued service. Following this award, Connaughton directly holds a total of 389,173 shares, including the RSUs, reflecting a routine compensation-related equity grant rather than an open-market purchase or sale.
CURTIS NICHOLAS T reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Chief Executive Officer Nicholas T. Curtis received a grant of 130,662 restricted stock units (RSUs) of common stock at no purchase price. Each RSU represents the right to receive one share of LENSAR common stock.
The RSUs vest in four substantially equal annual installments on each anniversary of the grant date, as long as he continues serving the company through each vesting date. After this award, Curtis directly holds 1,122,758 shares of LENSAR common stock.
WEISNER AIMEE S reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director Aimee S. Weisner received a grant of 17,421 restricted stock units (RSUs) of common stock as part of her annual non-employee director compensation. The award was granted at no cash cost per unit and is structured as equity-based compensation rather than an open-market purchase.
Each RSU represents the right to receive one share of LENSAR common stock, vesting in full on June 3, 2027, provided she continues serving the company through that date. The RSUs may also settle earlier upon her termination of service, a change in control of the company, or her death or disability. Following this grant, she is reported to own 110,368 shares directly.
O'Farrell Elizabeth G. reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director Elizabeth G. O'Farrell received an equity grant of 17,421 restricted stock units of common stock as part of her annual non-employee director compensation. Each RSU represents one share of common stock and vests in full on June 3, 2027, subject to her continued service to the company.
The RSUs will be settled upon the earliest of her termination of service, a change in control of the company, or her death or disability. Following this grant, she holds 67,368 shares of common stock directly.